Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Siân Rizzo"'
Autor:
Robert Brown, Stanley B. Kaye, David L. Hudson, Garry Box, Craig P Carden, Ian Titley, Louisa Luk, Daniel Liber, Alessandra Santos-Silva, Wei Dai, Paul Mellor, Jenny M. Hersey, Siân Rizzo
Supplementary Table 1 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bfdec21618bcf0f5568ae2f5dfdeddd
https://doi.org/10.1158/1535-7163.22496746
https://doi.org/10.1158/1535-7163.22496746
Autor:
Robert Brown, Stanley B. Kaye, David L. Hudson, Garry Box, Craig P Carden, Ian Titley, Louisa Luk, Daniel Liber, Alessandra Santos-Silva, Wei Dai, Paul Mellor, Jenny M. Hersey, Siân Rizzo
Supplementary Table 2 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d31355882021f2be82866e47eb8296
https://doi.org/10.1158/1535-7163.22496743.v1
https://doi.org/10.1158/1535-7163.22496743.v1
Autor:
Robert Brown, Stanley B. Kaye, David L. Hudson, Garry Box, Craig P Carden, Ian Titley, Louisa Luk, Daniel Liber, Alessandra Santos-Silva, Wei Dai, Paul Mellor, Jenny M. Hersey, Siân Rizzo
Platinum-based chemotherapy, with cytoreductive surgery, is the cornerstone of treatment of advanced ovarian cancer; however, acquired drug resistance is a major clinical obstacle. It has been proposed that subpopulations of tumor cells with stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea5b177caa2cfe877dbe12141d550ff
https://doi.org/10.1158/1535-7163.c.6535381
https://doi.org/10.1158/1535-7163.c.6535381
Autor:
Robert S. Brown, Siân Rizzo, Alessandra Santos-Silva, Jenny M. Hersey, Craig P. Carden, Daniel Liber, Wei Dai, Garry Box, David Hudson, Louisa Luk, Stanley B. Kaye, Paul Mellor, Ian Titley
Publikováno v:
Molecular Cancer Therapeutics. 10:325-335
Platinum-based chemotherapy, with cytoreductive surgery, is the cornerstone of treatment of advanced ovarian cancer; however, acquired drug resistance is a major clinical obstacle. It has been proposed that subpopulations of tumor cells with stem cel
Autor:
Christopher J. Shepherd, Rosalind A. Eeles, Andrew Dodson, A Falconer, Gyula Kovacs, Sameer Jhavar, Janet Shipley, D.L. Hudson, A. R. Norman, J F Knight, Siân Rizzo, Michelle D. Garrett, Colin Cooper, Daniel Brewer
Publikováno v:
British Journal of Cancer
Prostate cancer is the most frequently diagnosed male cancer, and its clinical outcome is difficult to predict. The disease may involve the inappropriate expression of genes that normally control the proliferation of epithelial cells in the basal lay
Publikováno v:
Cell Proliferation. 38:363-374
The prostate gland is the site of the most commonly diagnosed cancer in men in USA and UK, accounting for one in five of new cases of male cancer. Common with many other cancer types, prostate cancer is believed to arise from a stem cell that shares
Autor:
Daniel Brewer, Gerhardt Attard, Christopher J. Shepherd, Ioanna Ledaki, Siân Rizzo, Melissa Davies, D.L. Hudson, Johann S. de Bono
Publikováno v:
The Prostate. 68(9)
BACKGROUND. Recent evidence suggests that prostate stem cells in benign and tumor tissue express the cell surface marker CD133, but these cells have not been well characterized. The aim of our study was to gene expression profile CD133-expressing cel